
Rabezat D 30mg/20mg Capsule SR
Marketer
Zemilon Biotech
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabezat D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication Rabezat D 30mg/20mg Sustained-Release Capsules. This treatment alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Rabezat D 30mg/20mg SR Capsules are determined by your physician and should be taken on an empty stomach. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically transient, side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cool milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Rabezat D 30mg/20mg Capsule SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Rabezat D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabezat D 30mg/20mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Administer Rabezat D 30mg/20mg SR capsules on an empty stomach.
Common Side effects of Rabezat D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Rabezat D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rabezat D 30mg/20mg SR Capsule whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Rabezat D 30mg/20mg Capsule SR works:
Rabezat D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to alleviate digestive discomfort. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabezat D 30mg/20mg SR Capsules concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Rabezat D 30mg/20mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rabezat D 30mg/20mg capsule is likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rabezat D 30mg/20mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Rabezat D 30mg/20mg sustained-release capsules to individuals with impaired renal function. Dosage modification of Rabezat D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Rabezat D 30mg/20mg SR capsules. Dosage modification may be necessary. Physician consultation is advised. Rabezat D 30mg/20mg SR capsules are contraindicated for patients experiencing moderate to severe hepatic dysfunction.
What if you forget to take Rabezat D 30mg/20mg Capsule SR :
Should you forget a Rabezat D 30mg/20mg Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabezat D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
